Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Debt to Equity (2016 - 2018)

Anaptysbio (ANAB) has disclosed Debt to Equity for 3 consecutive years, with $0.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Debt to Equity fell 94.77% year-over-year to $0.0, compared with a TTM value of $0.0 through Dec 2018, down 94.77%, and an annual FY2018 reading of $0.0, down 94.77% over the prior year.
  • Debt to Equity was $0.0 for Q4 2018 at Anaptysbio, down from $0.0 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.12 in Q1 2017 and bottomed at -$0.36 in Q4 2016.
  • Average Debt to Equity over 3 years is $0.0, with a median of $0.02 recorded in 2018.
  • The sharpest move saw Debt to Equity skyrocketed 106.8% in 2017, then tumbled 94.77% in 2018.
  • Year by year, Debt to Equity stood at -$0.36 in 2016, then surged by 106.8% to $0.02 in 2017, then tumbled by 94.77% to $0.0 in 2018.
  • Business Quant data shows Debt to Equity for ANAB at $0.0 in Q4 2018, $0.0 in Q3 2018, and $0.01 in Q2 2018.